Taxonomy

Could MRI Help Speed Up CMT1A Research? New Findings from Professor Mary M. Reilly, MBE

A newly published study led by CMTA’s Strategy to Accelerate

Read More

CMTA Invests $210K in Long-Read Sequencing to Accelerate CMT Gene Discovery

Today, the Charcot-Marie-Tooth Association (CMTA) announced a $210,000 investment to

Read More

CMT2F Study Achieves Recruitment Goal, Expands to Include Additional Participants

An international team of researchers from the Inherited Neuropathies Consortium

Read More

CMTA-STAR Advisory Board Member Dr. D’Antonio Publishes in Brain, Identifies Potential Therapeutic Target for CMT1B

CMTA is proud to share that research led by CMTA

Read More

Accelerating Genetic Therapy for CMT4B1: A CMTA Research Update

With CMTA’s support, researchers at San Raffaele Scientific Institute in

Read More

CMTA’s $300K Investment in CRISPR for CMT2A

The Charcot-Marie-Tooth Association (CMTA) is investing $300,000 in a groundbreaking

Read More

What’s New in CMT Research and Care? A 2025 Update Published by CMTA-STAR Advisory Board Member Davide Pareyson, MD

CMTA Strategy To Accelerate Research (CMTA-STAR) Advisory Board member and

Read More

CMTA Fuels Breakthrough Imaging Research to Address CMT2A’s Cellular Weakness

The Charcot-Marie-Tooth Association (CMTA) announces a $90,860 investment in a

Read More

Episode 3 of the Simply CMT Podcast with Dr. Katherine Forsey

Join us as we talk with Dr. Katherine Forsey, CMTA’s

Read More

Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C

CMTA-STAR Alliance Partner Actio Biosciences has announced that the first

Read More